X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (92) 92
index medicus (79) 79
vasoplegia (62) 62
vasoplegia - drug therapy (55) 55
male (54) 54
cardiopulmonary bypass (45) 45
vasoplegia - etiology (43) 43
cardiac & cardiovascular systems (38) 38
female (38) 38
methylene blue - therapeutic use (37) 37
middle aged (37) 37
anesthesiology (36) 36
surgery (34) 34
aged (33) 33
methylene blue (32) 32
respiratory system (25) 25
risk factors (25) 25
treatment outcome (25) 25
septic shock (22) 22
vasoplegia - physiopathology (21) 21
vasoplegic syndrome (20) 20
cardiac surgery (19) 19
cardiac surgical procedures - adverse effects (18) 18
cardiac-surgery (18) 18
cardiopulmonary bypass - adverse effects (18) 18
enzyme inhibitors - therapeutic use (18) 18
methylene-blue (18) 18
peripheral vascular disease (18) 18
vasopressin (18) 18
hypotension (17) 17
shock (17) 17
transplantation (17) 17
nitric oxide (16) 16
adult (15) 15
anesthesia & perioperative care (15) 15
vasoconstrictor agents - therapeutic use (15) 15
critical care (14) 14
sepsis (14) 14
coronary artery bypass (13) 13
methylene blue - adverse effects (13) 13
nitric-oxide (13) 13
retrospective studies (13) 13
abridged index medicus (12) 12
blood pressure (12) 12
risk-factors (12) 12
animals (11) 11
health aspects (11) 11
heart surgery (11) 11
hydroxocobalamin (11) 11
mortality (11) 11
nitric-oxide synthase (11) 11
usage (11) 11
vasodilatory shock (11) 11
anesthesia (10) 10
critical care medicine (10) 10
dosage and administration (10) 10
heart (10) 10
methylene blue - administration & dosage (10) 10
postoperative complications - drug therapy (10) 10
shock - drug therapy (10) 10
vasoplegia - diagnosis (10) 10
catecholamine-refractory vasoplegia (9) 9
aged, 80 and over (8) 8
arginine-vasopressin (8) 8
care and treatment (8) 8
hydroxocobalamin - administration & dosage (8) 8
hypotension - etiology (8) 8
management (8) 8
norepinephrine (8) 8
research (8) 8
analysis (7) 7
diseases of the circulatory system (7) 7
fluid therapy (7) 7
hemodynamics - drug effects (7) 7
infusion (7) 7
medicine & public health (7) 7
outcomes (7) 7
pain medicine (7) 7
patients (7) 7
pediatrics (7) 7
systemic vascular-resistance (7) 7
vasoconstrictor agents - pharmacology (7) 7
vasoplegia - prevention & control (7) 7
blood pressure - drug effects (6) 6
complications and side effects (6) 6
heart valve prosthesis implantation - adverse effects (6) 6
hemodynamics (6) 6
hypotension - drug therapy (6) 6
postoperative complications - etiology (6) 6
prognosis (6) 6
time factors (6) 6
vasoconstrictor agents - administration & dosage (6) 6
vasoplegia - epidemiology (6) 6
vasoplegia - therapy (6) 6
angiotensin (5) 5
cardiac surgical procedures (5) 5
cardiothoracic surgery (5) 5
cohort studies (5) 5
dose-response relationship, drug (5) 5
drug (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Anesthesiology, ISSN 0003-3022, 01/2017, Volume 126, Issue 1, pp. 85 - 93
Journal Article
Journal Article
Journal Article
The heart surgery forum, 10/2017, Volume 20, Issue 5, p. E234
Vasoplegic syndrome is a form of vasodilatory shock that occurs frequently in patients who undergo cardiac surgery requiring cardiopulmonary bypass (CBP).... 
Postoperative Complications - etiology | Humans | Methylene Blue - therapeutic use | Vasoplegia - etiology | Vasoplegia - drug therapy | Cardiac Surgical Procedures - adverse effects | Postoperative Complications - drug therapy | Enzyme Inhibitors - therapeutic use
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 3/2011, Volume 25, Issue 3, pp. 429 - 436
Methylene blue has only recently been noted to cause severe central nervous system toxicity. Methylene blue is used for various conditions, including,... 
ANTIDEPRESSANT | serotonin toxicity | PSYCHIATRY | INFUSION | PROLONGED POSTOPERATIVE DISORIENTATION | monoamine oxidase inhibitor | IDENTIFICATION | NEUROSCIENCES | PARATHYROID SURGERY | CLINICAL NEUROLOGY | serotonin syndrome | ENCEPHALOPATHY | VASOPLEGIA | methylene blue | MIRTAZAPINE | TOXICOKINETICS | INHIBITION | PHARMACOLOGY & PHARMACY | serotonin reuptake inhibitor | Severity of Illness Index | Methylene Blue - pharmacokinetics | Monoamine Oxidase Inhibitors - adverse effects | Humans | Serotonin Uptake Inhibitors - adverse effects | Monoamine Oxidase Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Methylene Blue - administration & dosage | Monoamine Oxidase Inhibitors - pharmacokinetics | Serotonin Syndrome - chemically induced | Animals | Central Nervous System Diseases - chemically induced | Drug Interactions | Methylene Blue - adverse effects | Serotonin Uptake Inhibitors - administration & dosage | Serotonin - metabolism | Serotonin Syndrome - physiopathology | Central Nervous System Diseases - physiopathology | Analysis | Drug interactions | Central nervous system | Physiological aspects | Serotonin uptake inhibitors | Dosage and administration | Methemoglobinemia | Drug therapy | Health aspects | Methylene blue | Drugs | Intravenous administration | Dyes | Serotonin | Toxicity | Oxidase | Nervous system | Criteria | Parathyroidectomy | Amine oxidase (flavin-containing) | Consonants (speech) | Side effects | Inhibitors | Antidepressants | Index Medicus
Journal Article